Healthcare provider profile · identity verified

Dean Christopher Bailey, MD

Family Practice · PERRYSBURG, OH · NPI 1780704445

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	844	208
Levothyroxine Sodium	Levothyroxine Sodium	404	99
Amlodipine Besylate	Amlodipine Besylate	390	98
Losartan Potassium	Losartan Potassium	322	84
Lisinopril	Lisinopril	310	87
Pantoprazole Sodium	Pantoprazole Sodium	287	73
Omeprazole	Omeprazole	247	62
Gabapentin	Gabapentin	224	50
Metformin Hcl	Metformin Hcl	224	63
Rosuvastatin Calcium	Rosuvastatin Calcium	216	60
Metoprolol Succinate	Metoprolol Succinate	186	41
Sertraline Hcl	Sertraline Hcl	185	47
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	178	44
Tamsulosin Hcl	Tamsulosin Hcl	170	44
Hydrochlorothiazide	Hydrochlorothiazide	160	44
Simvastatin	Simvastatin	156	46
Potassium Chloride	Potassium Chloride	131	26
Allopurinol	Allopurinol	123	31
Alendronate Sodium	Alendronate Sodium	122	28
Meloxicam	Meloxicam	119	38
Carvedilol	Carvedilol	108	28
Metoprolol Tartrate	Metoprolol Tartrate	102	28
Metformin Hcl Er	Metformin Hcl	101	27
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	95	25
Tramadol Hcl	Tramadol Hcl	90	24
Eliquis	Apixaban	88	16
Ozempic	Semaglutide	87	11
Citalopram Hbr	Citalopram Hydrobromide	83	20
Trazodone Hcl	Trazodone Hcl	76	18
Escitalopram Oxalate	Escitalopram Oxalate	73	22
Albuterol Sulfate Hfa	Albuterol Sulfate	72	26
Alprazolam	Alprazolam	70	25
Fenofibrate	Fenofibrate Nanocrystallized	69	15
Fluticasone Propionate	Fluticasone Propionate	69	29
Clopidogrel	Clopidogrel Bisulfate	68	21
Prednisone	Prednisone	66	38
Glipizide Er	Glipizide	64	19
Cefuroxime	Cefuroxime Axetil	63	57
Synthroid	Levothyroxine Sodium	59	16
Doxycycline Hyclate	Doxycycline Hyclate	57	51
Nifedipine Er	Nifedipine	52	12
Farxiga	Dapagliflozin Propanediol	51	13
Zolpidem Tartrate	Zolpidem Tartrate	51	12
Finasteride	Finasteride	49	15
Spironolactone	Spironolactone	46	15
Furosemide	Furosemide	45	20
Tizanidine Hcl	Tizanidine Hcl	45	suppressed
Ezetimibe	Ezetimibe	44	11
Duloxetine Hcl	Duloxetine Hcl	43	suppressed
Glipizide	Glipizide	42	suppressed
Atenolol	Atenolol	40	13
Famotidine	Famotidine	40	suppressed
Pregabalin	Pregabalin	39	suppressed
Klor-Con M20	Potassium Chloride	38	12
Montelukast Sodium	Montelukast Sodium	36	11
Pravastatin Sodium	Pravastatin Sodium	36	11
Buspirone Hcl	Buspirone Hcl	35	11
Celecoxib	Celecoxib	34	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	34	suppressed
Donepezil Hcl	Donepezil Hcl	33	11
Baclofen	Baclofen	31	suppressed
Bumetanide	Bumetanide	31	suppressed
Meclizine Hcl	Meclizine Hcl	31	suppressed
Mirtazapine	Mirtazapine	31	suppressed
Fenofibrate	Fenofibrate	29	suppressed
Januvia	Sitagliptin Phosphate	29	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	29	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	28	suppressed
Valacyclovir	Valacyclovir Hcl	28	suppressed
Bupropion Xl	Bupropion Hcl	27	suppressed
Valsartan	Valsartan	25	suppressed
Glimepiride	Glimepiride	24	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	23	13
Sumatriptan Succinate	Sumatriptan Succinate	23	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	23	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	22	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	22	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	22	suppressed
Ramipril	Ramipril	21	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	21	suppressed
Trulicity	Dulaglutide	21	suppressed
Ropinirole Hcl	Ropinirole Hcl	20	suppressed
Acyclovir	Acyclovir	18	suppressed
Azelastine Hcl	Azelastine Hcl	18	suppressed
Azithromycin	Azithromycin	18	15
Digoxin	Digoxin	18	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	18	suppressed
Primidone	Primidone	18	suppressed
Propranolol Hcl Er	Propranolol Hcl	18	suppressed
Advair Hfa	Fluticasone Propion/Salmeterol	17	suppressed
Hydralazine Hcl	Hydralazine Hcl	17	suppressed
Lovastatin	Lovastatin	17	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	17	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	17	15
Breo Ellipta	Fluticasone/Vilanterol	16	suppressed
Chlorthalidone	Chlorthalidone	16	suppressed
Diclofenac Sodium	Diclofenac Sodium	16	suppressed
Bupropion Hcl Sr	Bupropion Hcl	15	suppressed
Cephalexin	Cephalexin	15	14
Colchicine	Colchicine	15	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	15	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	15	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	15	suppressed
Repatha Syringe	Evolocumab	15	suppressed
Glyburide-Metformin Hcl	Glyburide/Metformin Hcl	14	suppressed
Myrbetriq	Mirabegron	14	suppressed
Symbicort	Budesonide/Formoterol Fumarate	14	suppressed
Tresiba Flextouch U-100	Insulin Degludec	14	suppressed
Xarelto	Rivaroxaban	14	suppressed
Irbesartan	Irbesartan	13	suppressed
Methenamine Hippurate	Methenamine Hippurate	13	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	13	suppressed
Clonazepam	Clonazepam	12	suppressed
Clonidine Hcl	Clonidine Hcl	12	suppressed
Fluconazole	Fluconazole	12	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	12	suppressed
Levetiracetam	Levetiracetam	12	suppressed
Lorazepam	Lorazepam	12	suppressed
Ondansetron Hcl	Ondansetron Hcl	12	suppressed
Sotalol	Sotalol Hcl	12	suppressed
Terazosin Hcl	Terazosin Hcl	12	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	12	suppressed
Balsalazide Disodium	Balsalazide Disodium	11	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	11	suppressed
Jardiance	Empagliflozin	11	suppressed
Ondansetron Odt	Ondansetron	11	suppressed
Tradjenta	Linagliptin	11	suppressed
Warfarin Sodium	Warfarin Sodium	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error